Becton Dickinson Total Assets 2010-2024 | BDX
Becton Dickinson total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Becton Dickinson total assets for the quarter ending September 30, 2024 were $55.582B, a 4.84% increase year-over-year.
- Becton Dickinson total assets for 2023 were $52.78B, a 0.29% decline from 2022.
- Becton Dickinson total assets for 2022 were $52.934B, a 1.73% decline from 2021.
- Becton Dickinson total assets for 2021 were $53.866B, a 0.27% decline from 2020.
Becton Dickinson Annual Total Assets
(Millions of US $) |
| 2023 |
$52,780 |
| 2022 |
$52,934 |
| 2021 |
$53,866 |
| 2020 |
$54,012 |
| 2019 |
$51,765 |
| 2018 |
$53,904 |
| 2017 |
$37,734 |
| 2016 |
$25,586 |
| 2015 |
$26,478 |
| 2014 |
$12,447 |
| 2013 |
$12,149 |
| 2012 |
$11,361 |
| 2011 |
$10,430 |
| 2010 |
$9,651 |
| 2009 |
$9,305 |
Becton Dickinson Quarterly Total Assets
(Millions of US $) |
| 2024-06-30 |
$55,582 |
| 2024-03-31 |
$54,157 |
| 2023-12-31 |
$52,274 |
| 2023-09-30 |
$52,780 |
| 2023-06-30 |
$53,017 |
| 2023-03-31 |
$54,394 |
| 2022-12-31 |
$53,129 |
| 2022-09-30 |
$52,934 |
| 2022-06-30 |
$53,199 |
| 2022-03-31 |
$54,786 |
| 2021-12-31 |
$53,363 |
| 2021-09-30 |
$53,866 |
| 2021-06-30 |
$54,333 |
| 2021-03-31 |
$54,921 |
| 2020-12-31 |
$54,748 |
| 2020-09-30 |
$54,012 |
| 2020-06-30 |
$53,959 |
| 2020-03-31 |
$53,516 |
| 2019-12-31 |
$51,952 |
| 2019-09-30 |
$51,765 |
| 2019-06-30 |
$52,233 |
| 2019-03-31 |
$52,598 |
| 2018-12-31 |
$52,932 |
| 2018-09-30 |
$53,904 |
| 2018-06-30 |
$53,977 |
| 2018-03-31 |
$54,573 |
| 2017-12-31 |
$55,363 |
| 2017-09-30 |
$37,734 |
| 2017-06-30 |
$37,166 |
| 2017-03-31 |
$24,121 |
| 2016-12-31 |
$24,318 |
| 2016-09-30 |
$25,586 |
| 2016-06-30 |
$26,016 |
| 2016-03-31 |
$26,236 |
| 2015-12-31 |
$26,046 |
| 2015-09-30 |
$26,478 |
| 2015-06-30 |
$27,079 |
| 2015-03-31 |
$28,293 |
| 2014-12-31 |
$18,503 |
| 2014-09-30 |
$12,447 |
| 2014-06-30 |
$12,374 |
| 2014-03-31 |
$12,250 |
| 2013-12-31 |
$12,035 |
| 2013-09-30 |
$12,149 |
| 2013-06-30 |
$11,587 |
| 2013-03-31 |
$11,630 |
| 2012-12-31 |
$11,629 |
| 2012-09-30 |
$11,361 |
| 2012-06-30 |
$11,025 |
| 2012-03-31 |
$11,195 |
| 2011-12-31 |
$11,413 |
| 2011-09-30 |
$10,430 |
| 2011-06-30 |
$10,621 |
| 2011-03-31 |
$10,344 |
| 2010-12-31 |
$10,071 |
| 2010-09-30 |
$9,651 |
| 2010-06-30 |
$9,032 |
| 2010-03-31 |
$8,943 |
| 2009-12-31 |
$9,094 |
| 2009-09-30 |
$9,305 |
| 2009-06-30 |
$8,849 |
| 2009-03-31 |
$7,576 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
